Jun 5 |
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
|
May 14 |
Mural Oncology GAAP EPS of -$1.84; reaffirms financial guidance
|
May 14 |
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
|
Apr 24 |
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Mar 26 |
Mural Oncology plc GAAP EPS of -$3.57
|
Mar 26 |
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
|
Mar 5 |
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Mar 4 |
Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value
|
Feb 27 |
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
|
Feb 5 |
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|